Literature DB >> 17021053

Focal subnuclear distribution of progesterone receptor is ligand dependent and associated with transcriptional activity.

Rebecca L Arnett-Mansfield1, J Dinny Graham, Adrienne R Hanson, Patricia A Mote, Anne Gompel, Lyndee L Scurr, Natalie Gava, Anna de Fazio, Christine L Clarke.   

Abstract

The progesterone receptor (PR) is a critical mediator of progesterone action in the female reproductive system. Expressed in the human as two proteins, PRA and PRB, the receptor is a ligand-activated nuclear transcription factor that regulates transcription by interaction with protein cofactors and binding to specific response elements in target genes. We previously reported that PR was located in discrete subnuclear foci in human endometrium. In this study, we investigated the role of ligand in the formation of PR foci and their association with transcriptional activity. PR foci were detected in mouse uterus and normal human breast tissues and were more abundant when circulating progesterone was high. In human malignant tissues, PR foci were aberrant: foci were larger in endometrial cancers than in normal endometrium, and in breast cancers hormone-dependence was decreased. Chromatin disruption also increased foci size and decreased ligand dependence, suggesting that altered nuclear architecture may contribute to the aberrant PR foci observed in endometrial and breast cancers. In breast cancer cells, movement of PR into foci required exposure to ligand and was blocked by transcriptional inhibitors and by prolonged inhibition of proteasomal degradation. Foci contained PR dimers, and fluorescence resonance energy transfer demonstrated that PR foci contained the highest concentration of receptor dimers in the nucleus. PR in foci colocalized with transcription factors and nascent RNA transcripts only in the presence of ligand, and inhibition of coactivator recruitment inhibited PR foci formation. The demonstration that focal distribution of PR within the nucleus is associated with transcription suggests a link between the subnuclear distribution of PR and its transcriptional activity that is likely to be important for normal cellular function of PR.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17021053     DOI: 10.1210/me.2006-0041

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  17 in total

Review 1.  Progesterone receptors, their isoforms and progesterone regulated transcription.

Authors:  Britta M Jacobsen; Kathryn B Horwitz
Journal:  Mol Cell Endocrinol       Date:  2011-09-17       Impact factor: 4.102

Review 2.  Transcription factories: gene expression in unions?

Authors:  Heidi Sutherland; Wendy A Bickmore
Journal:  Nat Rev Genet       Date:  2009-07       Impact factor: 53.242

3.  High throughput, cell type-specific analysis of key proteins in human endometrial biopsies of women from fertile and infertile couples.

Authors:  Richard E Leach; Philip Jessmon; Christos Coutifaris; Michael Kruger; Evan R Myers; Rouba Ali-Fehmi; Sandra A Carson; Richard S Legro; William D Schlaff; Bruce R Carr; Michael P Steinkampf; Susan Silva; Phyllis C Leppert; Linda Giudice; Michael P Diamond; D Randall Armant
Journal:  Hum Reprod       Date:  2012-01-02       Impact factor: 6.918

4.  Cells in behaviourally relevant brain regions coexpress nuclear receptor coactivators and ovarian steroid receptors.

Authors:  M J Tetel; N K Siegal; S D Murphy
Journal:  J Neuroendocrinol       Date:  2007-04       Impact factor: 3.627

5.  Inhibiting Nuclear Phospho-Progesterone Receptor Enhances Antitumor Activity of Onapristone in Uterine Cancer.

Authors:  Yan Huang; Wei Hu; Jie Huang; Fangrong Shen; Yunjie Sun; Cristina Ivan; Sunila Pradeep; Robert Dood; Monika Haemmerle; Dahai Jiang; Lingegowda S Mangala; Kyunghee Noh; Jean M Hansen; Heather J Dalton; Rebecca A Previs; Archana S Nagaraja; Michael McGuire; Nicholas B Jennings; Russell Broaddus; Robert L Coleman; Anil K Sood
Journal:  Mol Cancer Ther       Date:  2017-12-13       Impact factor: 6.261

6.  In vitro mechanism for downregulation of ER-α expression by epigallocatechin gallate in ER+/PR+ human breast cancer cells.

Authors:  Francesca De Amicis; Alessandra Russo; Paola Avena; Marta Santoro; Adele Vivacqua; Daniela Bonofiglio; Loredana Mauro; Saveria Aquila; Donatella Tramontano; Suzanne A W Fuqua; Sebastiano Andò
Journal:  Mol Nutr Food Res       Date:  2013-01-16       Impact factor: 5.914

7.  Activation of estrogen-responsive genes does not require their nuclear co-localization.

Authors:  Silvia Kocanova; Elizabeth A Kerr; Sehrish Rafique; Shelagh Boyle; Elad Katz; Stephanie Caze-Subra; Wendy A Bickmore; Kerstin Bystricky
Journal:  PLoS Genet       Date:  2010-04-22       Impact factor: 5.917

Review 8.  Progesterone receptor isoform functions in normal breast development and breast cancer.

Authors:  Anastasia Kariagina; Mark D Aupperlee; Sandra Z Haslam
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2008       Impact factor: 1.807

Review 9.  Minireview: Progesterone Regulation of Proliferation in the Normal Human Breast and in Breast Cancer: A Tale of Two Scenarios?

Authors:  Heidi N Hilton; J Dinny Graham; Christine L Clarke
Journal:  Mol Endocrinol       Date:  2015-08-12

Review 10.  Progesterone action in human tissues: regulation by progesterone receptor (PR) isoform expression, nuclear positioning and coregulator expression.

Authors:  Katherine M Scarpin; J Dinny Graham; Patricia A Mote; Christine L Clarke
Journal:  Nucl Recept Signal       Date:  2009-12-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.